A Delaware judge threw out lawsuits seeking to link the heartburn drug Zantac to cancer, freeing makers of the product from ...

Study: Four out of 10 diabetics not aware of disease AIIMS exodus: 429 doctors quit 20 institutes in 3 years; 1 of every 3 faculty posts vacant AIIMS exodus: 429 doctors quit 20 institutes in 2 years ...

FDA allows reformulated ranitidine back on the market More than five years after the US Food and Drug Administration (FDA) asked manufacturers to pull drugs with ranitidine off the shelves due to ...

NEW YORK, July 31 (Praxis Press) Previous studies have shown that omeprazole sodium is more effective than ranitidine hydrochloride in controlling symptoms of heartburn in patients with ...

Drug regulator Drugs Controller General of India has asked drug controllers of all states and Union Territories to direct manufacturers under their jurisdiction to monitor the presence of a ...

Following reports of NDMA impurity, CDSCO has directed state drug controllers to monitor NDMA levels in Ranitidine, a common antacid. An expert panel recommended a larger committee to investigate ...

The Central Drugs Standard Control Organisation (CDSCO) has directed all state and union territory drug regulators to ensure manufacturers of Ranitidine -- a commonly used acidity medicine --monitor ...

In a renewed move to safeguard public health, the Drugs Controller General of India (DCGI) has directed all state and union territory drug regulators to ensure that manufacturers of Ranitidine—a ...

The government may consider a nationwide ban on the widely used antacid ranitidine after an expert committee reportedly submitted a detailed report highlighting its potential cancer risks. According ...

After years of deliberation, India is likely to ban the widely used over-the-counter (OTC) antacid Ranitidine due to cancer-causing concerns, News18 has learnt. The ban has been recommended by an ...